Literature DB >> 23630356

Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis.

Kyra A Oswald-Richter1, Bradley W Richmond, Nicole A Braun, Joan Isom, Susamma Abraham, Thyneice R Taylor, John M Drake, Daniel A Culver, David S Wilkes, Wonder P Drake.   

Abstract

Sarcoidosis pathogenesis is characterized by peripheral anergy and an exaggerated, pulmonary CD4(+) Th1 response. In this study, we demonstrate that CD4(+) anergic responses to polyclonal TCR stimulation are present peripherally and within the lungs of sarcoid patients. Consistent with prior observations, spontaneous release of IL-2 was noted in sarcoidosis bronchoalveolar lavage CD4(+) T cells. However, in contrast to spontaneous hyperactive responses reported previously, the cells displayed anergic responses to polyclonal TCR stimulation. The anergic responses correlated with diminished expression of the Src kinase Lck, protein kinase C-θ, and NF-κB, key mediators of IL-2 transcription. Although T regulatory (Treg) cells were increased in sarcoid patients, Treg depletion from the CD4(+) T cell population of sarcoidosis patients did not rescue IL-2 and IFN-γ production, whereas restoration of the IL-2 signaling cascade, via protein kinase C-θ overexpression, did. Furthermore, sarcoidosis Treg cells displayed poor suppressive capacity indicating that T cell dysfunction was a global CD4(+) manifestation. Analyses of patients with spontaneous clinical resolution revealed that restoration of CD4(+) Th1 and Treg cell function was associated with resolution. Conversely, disease progression exhibited decreased Th1 cytokine secretion and proliferative capacity, and reduced Lck expression. These findings implicate normalized CD4(+) T cell function as a potential therapeutic target for sarcoidosis resolution.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23630356      PMCID: PMC3660530          DOI: 10.4049/jimmunol.1202891

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

Review 1.  T cell exhaustion.

Authors:  E John Wherry
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

2.  Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis.

Authors:  Nam-Sihk Lee; Laura Barber; Ali Kanchwala; Carter J H Childs; Yash P Kataria; Marc A Judson; Mark A Mazer; Sergio Arce
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

3.  Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis.

Authors:  Kyra A Oswald-Richter; Daniel A Culver; Charlene Hawkins; Rana Hajizadeh; Susamma Abraham; Bryan E Shepherd; Cathy A Jenkins; Marc A Judson; Wonder P Drake
Journal:  Infect Immun       Date:  2009-07-13       Impact factor: 3.441

4.  Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis.

Authors:  Kyra A Oswald-Richter; Dia C Beachboard; Xiaoyan Zhan; Christa F Gaskill; Susamma Abraham; Cathy Jenkins; Daniel A Culver; Wonder Drake
Journal:  Respir Res       Date:  2010-11-23

5.  Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis.

Authors:  F Idali; J Wahlström; C Müller-Suur; A Eklund; J Grunewald
Journal:  Clin Exp Immunol       Date:  2008-02-14       Impact factor: 4.330

6.  Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis.

Authors:  K Konishi; D R Moller; C Saltini; M Kirby; R G Crystal
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

Review 7.  Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumors.

Authors:  Matthew F Mescher; Flavia E Popescu; Michael Gerner; Chris D Hammerbeck; Julie M Curtsinger
Journal:  Semin Cancer Biol       Date:  2007-06-23       Impact factor: 15.707

8.  Mycolactone suppresses T cell responsiveness by altering both early signaling and posttranslational events.

Authors:  Sheerazed Boulkroun; Laure Guenin-Macé; Maria-Isabel Thoulouze; Marc Monot; Anaïs Merckx; Gordon Langsley; Georges Bismuth; Vincenzo Di Bartolo; Caroline Demangel
Journal:  J Immunol       Date:  2009-12-30       Impact factor: 5.422

9.  The immune paradox of sarcoidosis and regulatory T cells.

Authors:  Makoto Miyara; Zahir Amoura; Christophe Parizot; Cécile Badoual; Karim Dorgham; Salim Trad; Marianne Kambouchner; Dominique Valeyre; Catherine Chapelon-Abric; Patrice Debré; Jean-Charles Piette; Guy Gorochov
Journal:  J Exp Med       Date:  2006-01-23       Impact factor: 14.307

10.  HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.

Authors:  Kyra Oswald-Richter; Stacy M Grill; Nikki Shariat; Mindy Leelawong; Mark S Sundrud; David W Haas; Derya Unutmaz
Journal:  PLoS Biol       Date:  2004-07-13       Impact factor: 8.029

View more
  32 in total

1.  Solving the Conundrum: Immunogenetics of Sarcoidosis.

Authors:  Naftali Kaminski; Wonder P Drake
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

2.  Biological role of the soluble interleukin-2 receptor in sarcoidosis.

Authors:  Remi M M Vanmaris; Ger T Rijkers
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort.

Authors:  Bryan S Benn; Zoe Lehman; Sharon A Kidd; Melissa Ho; Sara Sun; Joris Ramstein; Nicholas K Arger; Christine P Nguyen; Robert Su; Antonio Gomez; Jeffrey M Gelfand; Laura L Koth
Journal:  Lung       Date:  2017-07-13       Impact factor: 2.584

4.  IL-13-regulated Macrophage Polarization during Granuloma Formation in an In Vitro Human Sarcoidosis Model.

Authors:  Landon W Locke; Elliott D Crouser; Peter White; Mark W Julian; Evelyn Guirado Caceres; Audrey C Papp; Van T Le; Wolfgang Sadee; Larry S Schlesinger
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

5.  Resolution of chronic ocular sarcoidosis with antimycobacterial therapy.

Authors:  Bradley W Richmond; Kyra Richter; Lloyd E King; Wonder P Drake
Journal:  Case Rep Intern Med       Date:  2014

6.  Declining Pulmonary Function in Interstitial Lung Disease Linked to Lymphocyte Dysfunction.

Authors:  Cody A Schott; Christian Ascoli; Yue Huang; David L Perkins; Patricia W Finn
Journal:  Am J Respir Crit Care Med       Date:  2020-03-01       Impact factor: 21.405

7.  Transcriptional survey of alveolar macrophages in a murine model of chronic granulomatous inflammation reveals common themes with human sarcoidosis.

Authors:  Arjun Mohan; Anagha Malur; Matthew McPeek; Barbara P Barna; Lynn M Schnapp; Mary Jane Thomassen; Sina A Gharib
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-12-06       Impact factor: 5.464

8.  Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis.

Authors:  W P Drake; B W Richmond; K Oswald-Richter; C Yu; J M Isom; J A Worrell; G R Shipley
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2013-11-25       Impact factor: 0.670

9.  Programmed Death-1 Inhibition of Phosphatidylinositol 3-Kinase/AKT/Mechanistic Target of Rapamycin Signaling Impairs Sarcoidosis CD4+ T Cell Proliferation.

Authors:  Lindsay J Celada; Joseph E Rotsinger; Anjuli Young; Guzel Shaginurova; Debresha Shelton; Charlene Hawkins; Wonder P Drake
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

10.  Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution.

Authors:  P Sakthivel; J Grunewald; A Eklund; D Bruder; J Wahlström
Journal:  Clin Exp Immunol       Date:  2015-11-24       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.